The aim of this work was to evaluate the inhibitory activities of different extracts of Asparagus racemosus
Introduction
Diabetes mellitus (DM) is a chronic disease caused by inherited or acquired deficiency in insulin secretion and by decreased responsiveness of the organs to the secreted insulin. Such a deficiency results in increased blood glucose level, which in turn can damage many of the body's systems, including blood vessels and nerves. 1 One of the therapeutic approaches is to decrease the postprandial hyperglycemia, by retarding the absorption of glucose by inhibition of carbohydrate-hydrolyzing enzymes, such as aamylase and a-glucosidase.
2 From this point of view, many efforts have been made to search for more effective and safe inhibitors of a-glucosidase and a-amylase from natural materials to develop physiological functional foods to treat diabetes. 3 Many traditional plants have been reported in India for diabetes, but only a small number of these have received scientific and medical evaluation to assess their efficacy. On the basis of ethno medical/tribal information Asparagus racemosus Willd has been used to treat and prevent diabetes. Asparagus racemosus Willd possess a diverse number of pharmacological activities including antioxidant and free radical scavenging activity, 4e6 anticholinesterase action 7, 8 and antiinflammatory property. However, the studies on anti-diabetic effects of Asparagus racemosus Willd extracts were not focused on the enzyme inhibitory activity thus, The present study is designed evaluate the in-vitro antidiabetic activity of extract of Asparagus racemosus Willd extracts and to understand how the extract acts against a-glucosidase and a-amylase enzymes.
Materials and methods

Identification of plant materials
The root plant of Asparagus racemosus Willd Family Asparagaceae was collected from the forests of Doddabetta in Nilgiris. The plant species was identified and authenticated by the Dr.S. Rajan, PhD Field Botanist Survey of Medicinal Plants and Collection Unit. Department of AYUSH Ministry of Health and Family Welfare, Govt of India. The plant was deposited in the herbarium of the Department of Pharmacognosy, JSS College of Pharmacy, Ooty. The leaves of the plant were used in study.
Chemicals
a-amylase from starch potato soluble, a-glucosidase from one gram of rat-intestinal acetone powder, p-nitrophenyl-a-D-glucopyranoside and dinitrosalicylic acid were purchased from Sigma chemicals. All the chemicals used in the study are of analytical grade.
Preparation of crude extract
The leaves of the plant were sun dried and ground to a coarse powder and stored in an air tight container. This coarse powder was subjected to successive extraction with n-hexane (68 C), chloroform (61 C), ethyl acetate (77 C), and methanol (64 C) by continuous soxhlation and aqueous extracts by maceration process. After collection of extracts, it is kept at temperature 37 C until solvent is completely evaporated. Then finally dried in desiccator.
Qualitative phytochemical analysis
The plant extracts of Asparagus racemosus Willd in n-hexane, chloroform, ethyl acetate, methanol and aqueous was analyzed for the presence of amino acids, steroids, cardiac glycosides, phenols, tannins, terpenoids, alkaloids, flavonoids, saponins, carbohydrates, reducing sugar. The total flavonoid content of the n-hexane, chloroform, ethylacetate, methanol and aqueous extracts of Asparagus racemosus Willd was determined by aluminium chloride colorimetric method.
In brief 50 mL of the n-hexane, chloroform, ethylacetate, methanol and aqueous extracts of Asparagus racemosus Willd (1mg//ml ethanol) were made up to 1 ml with methanol mixed with 4 ml of distilled water and then 0.3 ml of 5% sodium nitrite solution. 9 0.3 ml of 10% aluminium chloride solution was added after 5min of incubation and the mixture was allowed to stand for 6min. Then 2 ml of 1 mol/L sodium hydroxide solution were added and the final volume of the mixture was brought to 10 ml with double-distilled water. The mixture was allowed to stand for 15min and absorbance was measured at 510 nm. The total flavonoid content was calculated from a calibration curve. The result was expressed as mg rutin equivalent per g dry weight.
Total triterpenoid content
The content of n-hexane, chloroform, ethylacetate, methenol and aqueous extracts of Asparagus racemosus Willd obtained by the aforementioned method was determined according to Lu et al with a slight modification and then expressed as milligram ursolic acid equivalent/gram dry weight. Briefly after a 200-ml n-hexane, chloroform, ethylacetate, methanol and aqueous extracts of Asparagus racemosus Willd solution in a 10 ml volumetric flask was heated to evaporation in a water-bath 1 ml new mixed 5%w/v vanillin acetic solution and 1.8 ml sulfuric acid were added mixed and incubated at 70 C for 30min. 10 Then the mixed solution was cooled and diluted to 10 ml with acetic acid. The absorbance was measured at 573 nm against blank using a spectrophotometer. The blank consisted of all reagents and solvents without sample solution. The content was determined using the standard ursolic acid calibration curve.
a-amylase inhibition activity
The a -amylase solution (Prepare 25 ml in Reagent 7.3.1 using Starch Potato Soluble. Facilitate solubilization by heating the starch solution in a glass beaker directly on a heating/stir plate using constant stirring. Bring to boil and maintain the solution at this temperature for 15 min). Inhibitory activity of the n-hexane, chloroform, ethyl acetate, methanol and aqueous extracts of Asparagus racemosus Willd were determined. 11 Dry reside was dissolved in 1 ml of tris buffer solution (pH 9.1) 2 ml of 0.1 mol/L an ammonia solution and 2 ml n-hexane. A total of 250 mL of sample ana 125 mL of 0.02 M sodium phosphate buffer (pH 6.9 with 6 mM sodium chloride) containing a-amylase solution (0.5 mg//mL) was incubated at 25 C for 10 min. After preincubation, 250 mL of 1% starch solution in 0.02 M sodium phosphate buffer (pH 6.9 with 6 mM sodium chloride) was added to each tube at timed intervals. The reaction mixtures were then incubated at 25 C for 10 min. The reaction was stopped with 0.5 mL of dinitrosalicylic acid color reagent. The test tube was then incubated in a boiling water bath for 5 min and cooled to room temperature. The reaction mixture was then diluted by adding 5 mL of distilled water and absorbance was measured at 540 nm. Acarbose was used as the positive control. The a-amylase inhibitory activity was calculated as follow;
where A s and A c are the absorbance of the sample and the control respectively.
a-glucosidase inhibitory activity
The rat intestinal a-glucosidase assay was based on the method of Kwon et al., 12 with slight modifications. One gram of ratintestinal acetone powder was suspended in 3 mL of 0.9 % saline. The suspension was sonicated 12 times for 30 s at 4 C.After centrifugation (10,000 g, 30 min, 4 C), the resulting supernatant was used for the assay. 13 Fifty microliters of sample solution were pre-incubated with 100 lL of rat intestinal a-glucosidase solution at 37 C for 15 min. The a-glucosidase inhibitory activity of the nhexane,chloroform, ethylacetate, methanol and aqueous extracts of Asparagus racemosus Willd were determined. Dry reside was redissolved in 1 ml of tris buffer solution (pH 9.1) 2 ml of 0.1 mol/L an ammonia solution and 2 ml n-hexane. A mixture of 50 mL of sample and 100 mL of 0.1 M phosphate buffer (pH 6.9) contining aglucosidase solution (1 U//mL) was incubated in 96 well plares at 25 C for 10 min. After preincubation, 50 mL 0f 5 mM pNPG solution in 0.1 M phosphate buffer (pH 6.9) was added to each well at timed intervals. The reaction mixture was incubated at 25 C for 5 min. Before and after incubation, absorbance was recorded at 405 nm by micro plate reader. Acarbose was used the positive control. The aglucosidase inhibitory activity was expressed as percentage inhibition percent and was calculated as follows;
Results and discussion
Phytochemical analysis
The n-hexane, chloroform, ethyl acetate, methanol, and aqueous extracts of. Asparagus racemosus Willd showed the presence of major phytochemical constituents such as Flavonoids, Tannins and phenolic, Saponins, Amino acids, Protein (Table 1) .
Total flavonoid and triterpenoids content
The total flavonoid of n-hexane, chloroform, ethyl acetate, methanol, and aqueous extracts of. Asparagus racemosus Willd are given in Table 2 .The plant extracts (ethyl acetate, aqueous) showed dose dependent 23.45 ± 1.33 mg/g and 25.81 ± 0.82 mg/g respectively. The total triterpenoids of n-hexane, chloroform, ethyl acetate, methanol, and aqueous extracts of. Asparagus racemosus Willd are given in Table 2 and Fig. 1 . The plant extracts (ethyl acetate, aqueous) showed dose dependent 109.8 ± 5.6 mg/g and 95.6 ± 7.5 mg/g respectively.
Inhibition of a-amylase and a-glucosidase
The a-amylase inhibition of n-hexane, chloroform, ethyl acetate, methanol, and aqueous extracts of. Asparagus racemosus Willd are given in Table 3 . The plant extracts (ethyl acetate, aqueous) showed dose dependent a-amylase inhibition with IC 50 value 65.85 ± 1.19 and IC 50 value 63.28 ± 0.38 respectively. The IC 50 value of Acarbose was found to be 11.84 ± 0.19. The a-glucosidase inhibition of nhexane, chloroform, ethyl acetate, methanol, and aqueous extracts of. Asparagus racemosus Willd are given in Table 3 . The plant extracts (ethyl acetate, aqueous) showed dose dependent a-glucosidase inhibition with IC 50 value 68.32 ± 1.02 and IC 50 value 62.65 ± 2.61 respectively. The IC 50 value of Acarbose was found to be 13.39 ± 0.11.
To maintain glycemic level in control, in both the fasting and post-prandial states is the treatment goal of diabetes patients. The suppression of glucose production from carbohydrates in the gut or glucose absorption from the intestine have been investigated using natural resources.
14 Pancreatic a-amylase is a key enzyme in the digestive system which catalyzes the initial step in the hydrolysis of starch, which is a principal source of glucose in the diet. a-glucosidase, a key enzyme for carbohydrate digestion, has been recognized as a therapeutic target for the modulation of postprandial hyperglycemia, which is the earliest metabolic abnormality to occur in type 2 Diabetes mellitus. a-amylase catalyzes the hydrolysis of a-1, 4-glucosidic linkages of starch, glycogen and various oligosaccharides and a eglucosidase further breaks down the disaccharides into simpler sugars, readily available for the intestinal absorption. The inhibition of their activity, in the digestive tract of humans, is considered to be effective to control diabetes by diminishing the absorption of glucose decomposed from starch by these enzymes. 15 Rat-derived a-glucosidase in the initial screening step of this study, because this stage is the most important for ensuring that the Average of three determinations, mean ± SEM. We have investigated that the Asparagus racemosus Willd which is used in traditional ayurvedic medicine for the treatment of several diseases, has been serving as anti-diabetic potential. Previously, this beneficial and priceless herb was not been investigated for its in vitro anti-diabetic activity. This herb has clearly recognized the potential of anti-diabetic activity and come out with the active principles responsible may be total flavonoids and terpenes content compound.
Flavonoids, like anti-oxidants, may prevent the progressive impairment of pancreatic beta-cell function due to oxidative stress and may thus reduce the occurrence of type 2 diabetes. Although, in the present study, the enzyme inhibitory activity of these extract and fractions were assayed in-vitro, the results from this work should be relevant to the human body. In addition to a-amylase and a-glucosidase inhibitory activities, these phytoconstituents are also reported to have several other biological activities including antibacterial, anti-oxidative,anti-cancer etc. 19 This supportive evidence further increases the medicinal importance of this Asparagus racemosus Willd indicating that this herb is not only beneficial for diabetes but also may be useful to a number of other human health complications.
Conclusion
The plant extract of the Asparagus racemosus Willd, has been used for food and medicinal purposes. Our result suggest the inhibitory effects on a-amylase and a-glucosidase and contains a high amount of phytochemical constituents (i.e., total flavonoids and triterpenoids content) Thus, the plant extract of the Asparagus racemosus Willd may be used in the management of type 2 diabetes mellitus with few or no side effects. However, Further studies of the plant extract of the Asparagus racemosus Willd using in vitro and in vivo models need to be performed to elucidate its insulin mimetic activity and reduction of insulin resistance and also to develop medicinal preparations, nutraceuticals or functional foods for diabetes and related symptoms.
